Cover page
Cover page - shares | 3 Months Ended | |
Mar. 31, 2022 | May 06, 2022 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-40465 | |
Entity Registrant Name | Marqeta, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 27-4306690 | |
Entity Address, Address Line One | 180 Grand Avenue | |
Entity Address, Address Line Two | 6th Floor | |
Entity Address, City or Town | Oakland | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94612 | |
City Area Code | 888 | |
Local Phone Number | 462-7738 | |
Title of 12(b) Security | Class A common stock, $0.0001 par value per share | |
Trading Symbol | MQ | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Central Index Key | 0001522540 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Amendment Flag | false | |
Document Fiscal Period Focus | Q1 | |
Class A Common Stock | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 432,784,327 | |
Class B Common Stock | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 111,656,849 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 1,197,257 | $ 1,247,581 |
Restricted cash | 7,800 | 7,800 |
Marketable securities | 447,046 | 452,875 |
Accounts receivable, net | 9,017 | 13,187 |
Settlements receivable, net | 9,093 | 11,266 |
Network incentives receivable | 45,721 | 30,399 |
Prepaid expenses and other current assets | 43,789 | 35,617 |
Total current assets | 1,759,723 | 1,798,725 |
Property and equipment, net | 9,120 | 9,687 |
Operating lease right-of-use assets, net | 10,748 | 11,296 |
Other assets | 5,856 | 2,286 |
Total assets | 1,793,483 | 1,830,378 |
Current liabilities: | ||
Accounts payable | 1,698 | 2,693 |
Revenue share payable | 130,045 | 121,179 |
Accrued expenses and other current liabilities | 102,146 | 114,096 |
Total current liabilities | 233,889 | 237,968 |
Operating lease liabilities, net of current portion | 11,618 | 12,427 |
Equity method investment | 8,036 | 8,384 |
Other liabilities | 4,344 | 6,557 |
Total liabilities | 249,851 | 256,952 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value; 100,000,000 and 100,000,000 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively | 0 | 0 |
Common stock, $0.0001 par value: 1,500,000,000 and 1,500,000,000 Class A shares authorized, 431,305,181 and 421,792,153 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively. 600,000,000 and 600,000,000 Class B shares authorized, 112,302,435 and 119,591,365 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively | 54 | 54 |
Additional paid-in capital | 2,029,745 | 1,993,055 |
Accumulated other comprehensive loss | (8,116) | (2,230) |
Accumulated deficit | (478,051) | (417,453) |
Total stockholders’ equity | 1,543,632 | 1,573,426 |
Total liabilities and stockholders’ equity | $ 1,793,483 | $ 1,830,378 |
Preferred Stock, shares issued (in shares) | 0 | 0 |
Preferred Stock, shares outstanding (in shares) | 0 | 0 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) Parentheticals - $ / shares | Mar. 31, 2022 | Dec. 31, 2021 |
Preferred Stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred Stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred Stock, shares issued (in shares) | 0 | 0 |
Preferred Stock, shares outstanding (in shares) | 0 | 0 |
Class A Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 1,500,000,000 | 1,500,000,000 |
Common stock, shares issued (in shares) | 431,305,181 | 421,792,153 |
Common stock, shares, outstanding (in shares) | 431,305,181 | 421,792,153 |
Class B Common Stock | ||
Common stock, shares authorized (in shares) | 600,000,000 | 600,000,000 |
Common stock, shares issued (in shares) | 112,302,435 | 119,591,365 |
Common stock, shares, outstanding (in shares) | 112,302,435 | 119,591,365 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Income Statement [Abstract] | ||
Net revenue | $ 166,102 | $ 107,983 |
Costs of revenue | 91,376 | 58,126 |
Gross profit | 74,726 | 49,857 |
Operating expenses: | ||
Compensation and benefits | 100,348 | 46,904 |
Technology | 4,770 | 4,196 |
Professional services | 11,384 | 5,626 |
Occupancy | 1,115 | 1,086 |
Depreciation and amortization | 979 | 907 |
Marketing and advertising | 559 | 495 |
Other operating expenses | 4,843 | 1,295 |
Total operating expenses | 123,998 | 60,509 |
Loss from operations | (49,272) | (10,652) |
Other income (expense), net | (11,677) | (2,167) |
Loss before income tax expense | (60,949) | (12,819) |
Income tax expense (benefit) | (351) | 19 |
Net loss | (60,598) | (12,838) |
Other comprehensive income (loss), net of taxes: | ||
Change in foreign currency translation adjustment | (19) | (14) |
Change in unrealized gain (loss) on marketable securities | (5,867) | (31) |
Net other comprehensive income (loss) | (5,886) | (45) |
Comprehensive loss | $ (66,484) | $ (12,883) |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.11) | $ (0.10) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.11) | $ (0.10) |
Weighted-average shares used in computing net loss per share attributable to common stockholders - Basic (in shares) | 542,565,992 | 130,841,306 |
Weighted-average shares used in computing net loss per share attributable to common stockholders - Diluted (in shares) | 542,565,992 | 130,841,306 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (loss) | Accumulated Deficit |
Redeemable Convertible Preferred Stock Beginning Balance (in shares) at Dec. 31, 2020 | 351,844,340 | ||||
Redeemable Convertible Preferred Stock Beginning Balance at Dec. 31, 2020 | $ 501,881 | ||||
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Mar. 31, 2021 | 351,844,340 | ||||
Redeemable Convertible Preferred Stock Ending Balance at Mar. 31, 2021 | $ 501,881 | ||||
Balance at the beginning of the period (in shares) at Dec. 31, 2020 | 130,312,838 | ||||
Balance at the beginning of the period at Dec. 31, 2020 | (213,717) | $ 13 | $ 39,769 | $ 25 | $ (253,524) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock upon exercise of vested options (in shares) | 1,904,186 | ||||
Issuance of common stock upon exercise of options | $ 1,410 | 1,410 | |||
Issuance of common stock upon early exercise of unvested options ( in shares) | 319,883 | ||||
Repurchase of early exercised stock options (in shares) | (18,567) | ||||
Issuance of common stock upon exercise of common stock warrants | $ 223 | 223 | |||
Share-based compensation expense | 11,392 | 11,392 | |||
Change in other comprehensive income (loss) | (45) | (45) | |||
Net loss | (12,838) | (12,838) | |||
Balance at the end of the period (in shares) at Mar. 31, 2021 | 132,518,340 | ||||
Balance at the end of the period at Mar. 31, 2021 | $ (213,575) | $ 13 | 52,794 | (20) | (266,362) |
Redeemable Convertible Preferred Stock Beginning Balance (in shares) at Dec. 31, 2021 | 0 | ||||
Redeemable Convertible Preferred Stock Beginning Balance at Dec. 31, 2021 | $ 0 | ||||
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Mar. 31, 2022 | 0 | ||||
Redeemable Convertible Preferred Stock Ending Balance at Mar. 31, 2022 | $ 0 | ||||
Balance at the beginning of the period (in shares) at Dec. 31, 2021 | 541,383,518 | ||||
Balance at the beginning of the period at Dec. 31, 2021 | 1,573,426 | $ 54 | 1,993,055 | (2,230) | (417,453) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock upon exercise of vested options (in shares) | 1,604,022 | ||||
Issuance of common stock upon exercise of options | 2,285 | 2,285 | |||
Repurchase of early exercised stock options (in shares) | (22,751) | ||||
Issuance of common stock net settlement of restricted stock units (in shares) | 642,827 | ||||
Issuance of common stock upon net settlement of restricted stock units | (4,702) | (4,702) | |||
Vesting of common stock warrants | 2,102 | 2,102 | |||
Share-based compensation expense | 37,005 | 37,005 | |||
Change in other comprehensive income (loss) | (5,886) | (5,886) | |||
Net loss | (60,598) | (60,598) | |||
Balance at the end of the period (in shares) at Mar. 31, 2022 | 543,607,616 | ||||
Balance at the end of the period at Mar. 31, 2022 | $ 1,543,632 | $ 54 | $ 2,029,745 | $ (8,116) | $ (478,051) |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Cash Flows From Operating Activities: | ||
Net loss | $ (60,598) | $ (12,838) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 979 | 907 |
Share-based compensation expense | 37,005 | 11,392 |
Non-cash operating leases expense | 548 | 522 |
Amortization of premium on marketable securities | 184 | 360 |
Impairment of other financial instruments | 11,616 | 0 |
Other | 282 | 2,324 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 4,223 | 5,032 |
Settlements receivable | 2,173 | 1,509 |
Network incentives receivable | (15,322) | (12,055) |
Prepaid expenses and other assets | (21,256) | (426) |
Accounts payable | (801) | (43) |
Revenue share payable | 8,866 | 14,122 |
Accrued expenses and other liabilities | (13,937) | 7,750 |
Operating lease liabilities | (721) | (686) |
Net cash (used in) provided by operating activities | (46,759) | 17,870 |
Cash flows from investing activities: | ||
Purchases of property and equipment | (612) | (604) |
Purchases of marketable securities | (10,022) | (7,002) |
Maturities of marketable securities | 9,800 | 16,366 |
Net cash (used in) provided by investing activities | (834) | 8,760 |
Cash flows from financing activities: | ||
Proceeds from exercise of stock options, including early exercised stock options, net of repurchase of early exercised unvested options | 1,971 | 1,711 |
Taxes paid related to net share settlement of restricted stock units | (4,702) | 0 |
Payment of deferred offering costs | 0 | (1,144) |
Net cash (used in) provided by financing activities | (2,731) | 567 |
Net (decrease) increase in cash, cash equivalents, and restricted cash | (50,324) | 27,197 |
Cash, cash equivalents, and restricted cash- Beginning of period | 1,255,381 | 228,233 |
Cash, cash equivalents, and restricted cash - End of period | $ 1,205,057 | $ 255,430 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (unaudited) - Reconciliation of Cash, Cash Equivalents and Restricted Cash and Supplemental Disclosure of Non-cash Investing and Financing Activities - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Reconciliation of cash, cash equivalents, and restricted cash | ||
Cash and cash equivalents | $ 1,197,257 | $ 247,630 |
Restricted cash | 7,800 | 7,800 |
Total cash, cash equivalents, and restricted cash | 1,205,057 | 255,430 |
Supplemental disclosures of cash flow information: | ||
Cash paid for income taxes | 9 | 0 |
Supplemental disclosures of non-cash investing and financing activities: | ||
Purchase of property and equipment accrued and not yet paid | 997 | 140 |
Deferred offering costs not yet paid | $ 0 | $ 894 |
Business Overview and Basis of
Business Overview and Basis of Presentation | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Business Overview and Basis of Presentation | Business Overview and Basis of Presentation Marqeta, Inc., or the Company, creates digital payment technology for innovation leaders. The Company's modern card issuing platform, or the Platform, places control over payment transactions into the hands of its customers, or Customers, enabling them to develop modern, state-of-the-art product experiences. The Company provides all of its Customers with issuer processor services and for most of its Customers it also acts as a card program manager. The Company primarily earns revenue from processing card transactions for its Customers. The Company was incorporated in the state of Delaware in 2010 and is headquartered in Oakland, California, with offices in the United States, United Kingdom, and Australia and a presence in Singapore as of March 31, 2022. Initial Public Offering In June 2021, the Company completed an initial public offering, or the IPO, in which the Company issued and sold 52,272,727 shares of its newly authorized Class A common stock, which included 6,818,181 shares that were offered and sold pursuant to the full exercise of the underwriters’ option to purchase additional shares at a price of $27.00 per share. The Company received aggregate net proceeds of $1.3 billion after deducting underwriting discounts and commissions of $91.6 million and offering costs of $7.5 million. Immediately prior to the completion of the IPO, the Company filed its Amended and Restated Certificate of Incorporation authorizing a total of 1,500,000,000 shares of Class A common stock which entitles holders to one vote per share, 600,000,000 shares of Class B common stock which entitles holders to 10 votes per share, and 100,000,000 shares of undesignated preferred stock. All shares of common stock then outstanding were reclassified as Class B common stock and all redeemable convertible preferred stock then outstanding were converted into 351,844,340 shares of common stock on a one-for-one basis and reclassified into Class B common stock. In addition, 2,569,528 shares of common stock warrants were converted to an equivalent number of shares of Class B common stock warrants and 203,610 shares of convertible preferred stock warrants were converted to an equivalent number of shares of Class B common stock warrants. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or the SEC, for interim reporting. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on March 11, 2022. The accompanying condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in the Annual Report on Form 10-K. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments of a normal, recurring nature considered necessary for a fair presentation of the Company's consolidated financial position, results of operations, comprehensive loss, and cash flows for the interim periods presented. The interim results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022, or for any other future annual or interim period. Use of Estimates The preparation of the financial statements requires management to make estimates and assumptions relating to reported amounts of assets and liabilities, disclosure of contingent liabilities, and reported amounts of revenue and expenses. Significant estimates and assumptions relate to the fair value of equity awards and warrants, share-based compensation, the estimation of variable consideration in contracts with Customers, the reserve for contract contingencies and processing errors, the fair value of equity method investments and a purchase call option to acquire the remaining interest in the equity method investee, the incremental borrowing rate used to determine operating lease liabilities, the useful lives of property and equipment, and the collectability of accounts receivable. Actual results could differ materially from these estimates. Business Risks and Uncertainties The Company has incurred net losses since its inception. For the three months ended March 31, 2022, the Company incurred net losses of $60.6 million, and had an accumulated deficit of $478.1 million as of March 31, 2022. The Company expects losses from operations to continue for the foreseeable future as it incurs costs and expenses related to creating new products for Customers, acquiring new Customers, developing its brand, expanding into new geographies and developing the existing Platform infrastructure. The Company believes that its cash and cash equivalents of $1.2 billion and marketable securities of $447.0 million as of March 31, 2022 are sufficient to fund its operations through at least the next twelve months from the issuance of these financial statements. In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic. Since then, the COVID-19 pandemic has continued to spread throughout the United States and the world. The prolonged disruption to the economy and the long-term financial impact of the pandemic cannot be reasonably estimated. The Company continues to monitor the situation and may take actions that alter its operations and business practices as may be required by federal, state, or local authorities or that the Company determines are in the best interests of its Customers, vendors, and employees. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in “Consolidated Financial Statements — Note 2. Summary of Significant Accounting Policies” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. There have been no significant changes to these policies during the three months ended March 31, 2022. Segment Information The Company operates as a single operating segment. The Company's chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, allocating resources, and evaluating the Company's financial performance. For the three months ended March 31, 2022 and 2021, revenue outside of the United States, based on the billing address of the Customer, was not material. As of March 31, 2022 and December 31, 2021, long-lived assets located outside of the United States were not material. Restricted Cash Restricted cash consists of deposits with financial institutions that issue payment cards (credit, debit, or prepaid) either on their own behalf or on behalf of businesses that issue customized card products to their end users, or Issuing Banks, to provide the Issuing Bank collateral in the event that Customers’ funds are not deposited at the Issuing Banks in time to settle Customers’ transactions with the networks that provide the infrastructure for settlement and card payment information flows, or Card Networks. Restricted cash also includes cash used to secure a letter of credit for the Company’s lease of its office headquarters in Oakland, California. New Accounting Standards Not Yet Adopted As an emerging growth company, the Jumpstart Our Business Startups Act, or the JOBS Act, allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption date discussed below reflects this election. In June 2016, the FASB issued ASU No. 2016-13, Financial instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . ASU 2016-13 replaces the incurred loss model with the current expected credit loss, or CECL, model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The CECL model requires a company to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance will be effective for the Company beginning January 1, 2023. The amendment requires a modified retrospective approach by recording a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Early adoption is permitted. The Company is still evaluating the impact this ASU will have on its condensed consolidated financial statements. |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Disaggregation of Revenue The following table provides information about disaggregated revenue from Customers: Three Months Ended March 31, 2022 2021 Platform services revenue, net $ 160,999 $ 106,453 Other services revenue 5,103 1,530 Total net revenue $ 166,102 $ 107,983 Contract Balances The following table provides information about contract assets and deferred revenue: Contract balance Balance sheet line reference March 31, December 31, Contract assets - current Prepaid expenses and other current assets $ 627 $ 950 Contract assets - non-current Other assets 827 927 Total contract assets $ 1,454 $ 1,877 Deferred revenue - current Accrued expenses and other current liabilities $ 18,839 $ 19,060 Deferred revenue - non-current Other liabilities 3,894 6,107 Total deferred revenue $ 22,733 $ 25,167 Net revenue recognized during the three months ended March 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $4.5 million and $0.8 million, respectively. Remaining Performance Obligations The Company has performance obligations associated with commitments in Customer contracts for future stand-ready obligations to process transactions throughout the contractual term. |
Marketable Securities
Marketable Securities | 3 Months Ended |
Mar. 31, 2022 | |
Investments [Abstract] | |
Marketable Securities | Marketable Securities The amortized cost, unrealized gain (loss), and estimated fair value of the Company's investments in securities available for sale consisted of the following: March 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Marketable securities U.S. government securities $ 420,277 $ — $ (7,824) $ 412,453 Commercial paper 15,972 — — 15,972 Asset-backed securities — — — — Corporate debt securities 18,793 — (172) 18,621 Total marketable securities $ 455,042 $ — $ (7,996) $ 447,046 December 31, 2021 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Marketable securities U.S. government securities $ 420,392 $ — $ (2,107) $ 418,285 Commercial paper 13,878 — — 13,878 Asset-backed securities 2,003 — (1) 2,002 Corporate debt securities 18,731 3 (24) 18,710 Total marketable securities $ 455,004 $ 3 $ (2,132) $ 452,875 The Company had nineteen and eight separate marketable securities in unrealized loss positions as of March 31, 2022 and December 31, 2021, respectively. The Company did not identify any marketable securities that were other-than-temporarily impaired as of March 31, 2022 and December 31, 2021. The Company does not intend to sell any marketable securities that have unrealized losses on March 31, 2022 and it is not more likely than not that the Company will be required to sell such securities before any anticipated recovery. The following table summarizes the stated maturities of the Company’s marketable securities: March 31, 2022 December 31, 2021 Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value Due within one year $ 167,575 $ 165,767 $ 64,914 $ 64,879 Due after one year through two years 287,467 281,279 390,090 387,996 Total $ 455,042 $ 447,046 $ 455,004 $ 452,875 |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The Company’s financial instruments consist of cash equivalents, marketable securities, accounts receivable, unbilled Customers' receivable, settlements receivable, accounts payable, and accrued liabilities. Cash equivalents are stated at amortized cost, which approximates fair value at the balance sheet dates, due to the short period of time to maturity. Marketable securities are carried at fair value. Accounts receivable, unbilled Customers' receivable, settlements receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. The following tables present the fair value hierarchy for assets and liabilities measured at fair value: March 31, 2022 Level 1 Level 2 Level 3 Total Fair Value Cash equivalents Money market funds $ 1,155,612 $ — $ — $ 1,155,612 Marketable securities U.S. government securities 412,453 — — 412,453 Commercial paper — 15,972 — 15,972 Asset-backed securities — — — — Corporate debt securities — 18,621 — 18,621 Total assets $ 1,568,065 $ 34,593 $ — $ 1,602,658 December 31, 2021 Level 1 Level 2 Level 3 Total Fair Value Cash equivalents Money market funds $ 1,213,543 $ — $ — $ 1,213,543 Marketable securities U.S. government securities 418,284 — — 418,284 Commercial paper — 13,878 — 13,878 Asset-backed securities — 2,002 — 2,002 Corporate debt securities — 18,711 — 18,711 Total assets $ 1,631,827 $ 34,591 $ — $ 1,666,418 The Company classifies money market funds, commercial paper, U.S. government securities, asset-backed securities and corporate securities within Level 1 or Level 2 of the fair value hierarchy because the Company values these investments using quoted market prices or alternative pricing sources and models utilizing market observable inputs. There were no transfers of financial instruments between the fair value hierarchy levels during the three months ended March 31, 2022 and the year ended December 31, 2021. |
Certain Balance Sheet Component
Certain Balance Sheet Components | 3 Months Ended |
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Certain Balance Sheet Components | Certain Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: March 31, December 31, Prepaid hosting and data costs $ 22,599 $ 2,455 Prepaid expenses 7,408 6,492 Inventory 4,942 3,940 Prepaid insurance 1,955 3,546 Card program deposits 2,128 2,167 Contract assets 627 950 Other financial instruments — 11,616 Other current assets 4,130 4,451 Prepaid expenses and other current assets $ 43,789 $ 35,617 In 2021, the Company acquired a preferred equity interest in a private company that is accounted for under the equity method of accounting. Concurrent with this investment, the Company also acquired an option that gives the Company the right, but not the obligation, to purchase all of the remaining equity interests of the private company. During the three months ended March 31, 2022, the Company recorded an impairment of $11.6 million related to this option. Property and Equipment, net Property and equipment consisted of the following: March 31, December 31, Leasehold improvements $ 8,110 $ 8,110 Computer equipment 8,921 8,581 Furniture and fixtures 2,459 2,459 Internally developed and purchased software 2,993 2,954 22,483 22,104 Accumulated depreciation and amortization (13,363) (12,417) Property and equipment, net $ 9,120 $ 9,687 Depreciation and amortization expense was $1.0 million and $0.9 million for the three months ended March 31, 2022 and 2021, respectively. The Company did not capitalize any material internal-use software costs during the three months ended March 31, 2022 and 2021 because development costs meeting capitalization criteria were not material during the respective periods. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: March 31, December 31, Accrued costs of revenue $ 46,726 $ 41,339 Accrued compensation and benefits 17,718 32,954 Deferred revenue 18,839 19,060 Reserve for contract contingencies and processing errors 3,764 3,386 Operating lease liabilities, current portion 3,109 3,021 Accrued professional services 3,785 2,454 Other accrued liabilities 8,205 11,882 Accrued expenses and other current liabilities $ 102,146 $ 114,096 Other Liabilities Other liabilities consisted of the following: March 31, December 31, Deferred revenue, net of current portion $ 3,894 $ 6,107 Other long-term liabilities 450 450 Other liabilities $ 4,344 $ 6,557 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Operating Leases In 2016, the Company entered into a lease agreement for its corporate headquarters in Oakland, California for 19,000 square feet of office space, which was subsequently amended in 2018 and 2019, resulting in a total of 63,000 square feet of office space being leased. The non-cancellable operating lease expires in February 2026 and includes options to extend the lease term, generally at the then-market rates. The Company excludes extension options that are not reasonably certain to be exercised from its lease terms. The Company’s lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms. The Company is responsible for operating expenses that exceed the amount of base operating expenses as defined in the original lease agreement. The Company's operating lease costs are as follows: Three Months Ended March 31, 2022 2021 Operating lease cost $ 843 $ 869 Variable lease cost 157 112 Short-term lease cost 113 72 Total lease cost $ 1,113 $ 1,053 The Company does not have any sublease income and the Company’s lease agreements do not contain any residual value guarantees or material restrictive covenants. The weighted average remaining operating lease term and the weighted average discount rate used in the calculation of the Company's lease assets and lease liabilities were as follows: March 31, December 31, Weighted average remaining operating lease term (in years) 3.8 4.1 Weighted average discount rate 7.7% 7.7% Maturities of operating lease liabilities by year are as follows as of March 31, 2022: Remainder of 2022 $ 3,096 2023 4,239 2024 4,472 2025 4,599 2026 780 Total lease payments 17,186 Less imputed interest (2,459) Total operating lease liabilities $ 14,727 Supplemental cash flow information related to the Company's operating leases was as follows: Three Months Ended March 31, 2022 2021 Cash paid for operating lease liabilities $ 1,016 $ 1,033 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ — $ — Letters of Credit In connection with the lease for its corporate headquarters office space, the Company is required to provide the landlord a letter of credit in the amount of $1.5 million. The Company has secured this letter of credit by depositing $1.5 million with the issuing financial institution, which deposit is classified as restricted cash in the condensed consolidated balance sheets. Purchase Obligations As of March 31, 2022, the Company had non-cancellable purchase commitments with certain service providers and Issuing Banks of $227.6 million, payable over the next 5 years. These purchase obligations include $219.0 million related to minimum commitments as part of a cloud-computing service agreement. The remaining obligations are related to various service providers and Issuing Banks processing fees over the fixed, non-cancellable respective contract terms. Defined Contribution Plans The Company maintains defined contribution plans for eligible employees, including a 401(k) plan that covers substantially all of its U.S. based employees and to which the Company provides a matching contribution of 50% of the first 6% of compensation that an employee contributes. The matching contribution vests after one year of service. During the three months ended March 31, 2022 and 2021, the Company contributed a total of $2.2 million and $0.8 million to its defined contribution plans, respectively. Legal Contingencies From time to time in the normal course of business, the Company may be subject to various legal matters such as threatened or pending claims or proceedings. As of March 31, 2022 and December 31, 2021, there were no legal contingency matters, either individually or in aggregate, that would have a material adverse effect on the Company’s financial position, results of operations, or cash flows. Given the unpredictable nature of legal proceedings, the Company bases its assessment on the information available at the time. As additional information becomes available, the Company reassesses the potential liability and may revise the estimate. Settlement of Payment Transactions Generally, Customers deposit a certain amount of pre-funding into accounts maintained at Issuing Banks to settle their payment transactions. Such pre-funding amounts may only be used to settle Customers’ payment transactions and are not considered assets of the Company. As such, the funds held in Customers’ accounts at Issuing Banks are not reflected on the Company’s condensed consolidated balance sheets. If a Customer fails to deposit sufficient funds to settle a transaction, the Company is liable to the Issuing Bank to settle the transaction and would therefore incur losses if such amounts cannot be subsequently recovered from the Customer. Indemnifications In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. With respect to Issuing Banks, the Company indemnifies the Issuing Bank for losses the Issuing Bank may incur for non-compliance with applicable law and regulation, if those losses resulted from the Company’s failure to perform under its program agreement with the Issuing Bank. In addition, the Company has entered into indemnification agreements with its directors and certain officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon the Company to provide indemnification under such agreements and there are no claims that the Company is aware of that could have a material effect on its condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, or condensed consolidated statements of cash flows. The Company also includes service level commitments to its Customers warranting certain levels of performance and permitting those Customers to receive credits in the event the Company fails to meet the levels specified. |
Commitments and Contingencies | Commitments and Contingencies Operating Leases In 2016, the Company entered into a lease agreement for its corporate headquarters in Oakland, California for 19,000 square feet of office space, which was subsequently amended in 2018 and 2019, resulting in a total of 63,000 square feet of office space being leased. The non-cancellable operating lease expires in February 2026 and includes options to extend the lease term, generally at the then-market rates. The Company excludes extension options that are not reasonably certain to be exercised from its lease terms. The Company’s lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms. The Company is responsible for operating expenses that exceed the amount of base operating expenses as defined in the original lease agreement. The Company's operating lease costs are as follows: Three Months Ended March 31, 2022 2021 Operating lease cost $ 843 $ 869 Variable lease cost 157 112 Short-term lease cost 113 72 Total lease cost $ 1,113 $ 1,053 The Company does not have any sublease income and the Company’s lease agreements do not contain any residual value guarantees or material restrictive covenants. The weighted average remaining operating lease term and the weighted average discount rate used in the calculation of the Company's lease assets and lease liabilities were as follows: March 31, December 31, Weighted average remaining operating lease term (in years) 3.8 4.1 Weighted average discount rate 7.7% 7.7% Maturities of operating lease liabilities by year are as follows as of March 31, 2022: Remainder of 2022 $ 3,096 2023 4,239 2024 4,472 2025 4,599 2026 780 Total lease payments 17,186 Less imputed interest (2,459) Total operating lease liabilities $ 14,727 Supplemental cash flow information related to the Company's operating leases was as follows: Three Months Ended March 31, 2022 2021 Cash paid for operating lease liabilities $ 1,016 $ 1,033 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ — $ — Letters of Credit In connection with the lease for its corporate headquarters office space, the Company is required to provide the landlord a letter of credit in the amount of $1.5 million. The Company has secured this letter of credit by depositing $1.5 million with the issuing financial institution, which deposit is classified as restricted cash in the condensed consolidated balance sheets. Purchase Obligations As of March 31, 2022, the Company had non-cancellable purchase commitments with certain service providers and Issuing Banks of $227.6 million, payable over the next 5 years. These purchase obligations include $219.0 million related to minimum commitments as part of a cloud-computing service agreement. The remaining obligations are related to various service providers and Issuing Banks processing fees over the fixed, non-cancellable respective contract terms. Defined Contribution Plans The Company maintains defined contribution plans for eligible employees, including a 401(k) plan that covers substantially all of its U.S. based employees and to which the Company provides a matching contribution of 50% of the first 6% of compensation that an employee contributes. The matching contribution vests after one year of service. During the three months ended March 31, 2022 and 2021, the Company contributed a total of $2.2 million and $0.8 million to its defined contribution plans, respectively. Legal Contingencies From time to time in the normal course of business, the Company may be subject to various legal matters such as threatened or pending claims or proceedings. As of March 31, 2022 and December 31, 2021, there were no legal contingency matters, either individually or in aggregate, that would have a material adverse effect on the Company’s financial position, results of operations, or cash flows. Given the unpredictable nature of legal proceedings, the Company bases its assessment on the information available at the time. As additional information becomes available, the Company reassesses the potential liability and may revise the estimate. Settlement of Payment Transactions Generally, Customers deposit a certain amount of pre-funding into accounts maintained at Issuing Banks to settle their payment transactions. Such pre-funding amounts may only be used to settle Customers’ payment transactions and are not considered assets of the Company. As such, the funds held in Customers’ accounts at Issuing Banks are not reflected on the Company’s condensed consolidated balance sheets. If a Customer fails to deposit sufficient funds to settle a transaction, the Company is liable to the Issuing Bank to settle the transaction and would therefore incur losses if such amounts cannot be subsequently recovered from the Customer. Indemnifications In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. With respect to Issuing Banks, the Company indemnifies the Issuing Bank for losses the Issuing Bank may incur for non-compliance with applicable law and regulation, if those losses resulted from the Company’s failure to perform under its program agreement with the Issuing Bank. In addition, the Company has entered into indemnification agreements with its directors and certain officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon the Company to provide indemnification under such agreements and there are no claims that the Company is aware of that could have a material effect on its condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, or condensed consolidated statements of cash flows. The Company also includes service level commitments to its Customers warranting certain levels of performance and permitting those Customers to receive credits in the event the Company fails to meet the levels specified. |
Stock Incentive Plans
Stock Incentive Plans | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Stock Incentive Plans | Stock Incentive Plans The Company has granted share-based awards to employees, non-employee directors, and other service providers of the Company under the Amended and Restated 2011 Equity Incentive Plan (2011 Plan) and the 2021 Stock Option and Incentive Plan (2021 Plan), collectively, the Plans. The 2011 Plan was terminated in June 2021 in connection with the IPO but continues to govern the terms of outstanding awards that were granted prior to the IPO. Additionally, the Company offers an employee stock purchase plan (ESPP), which allows employees to purchase shares of common stock at 85% of the fair value of the Company’s Class A common stock on the first or last day of the offering period, whichever is lower. The offering periods are six months long and start in May and November of each year. The following table presents the share-based compensation expense recognized in the periods presented: Three Months Ended March 31, 2022 2021 Restricted stock units $ 15,345 $ — Stock options 7,659 5,505 CEO Long-Term Performance Award 13,121 — Employee Stock Purchase Plan 880 — Secondary sales of common stock — 5,887 Total $ 37,005 $ 11,392 Restricted Stock Units Commencing in 2020, the Company began granting restricted stock units, or RSUs, to employees. RSUs granted prior to April 1, 2021 vest upon the satisfaction of both a service condition and a liquidity condition, which was deemed satisfied in connection with the Company’s IPO on June 8, 2021. The service condition for these awards is satisfied over four years. Because the liquidity condition had not been satisfied as of March 31, 2021, the Company had not recorded any share-based compensation expense for the RSUs at that date. RSUs granted on or after April 1, 2021, vest upon the satisfaction of a service condition. The service condition for these awards is satisfied over four years. In the three months ended March 31, 2022, the Company recognized $15.3 million of share-based compensation expense related to these RSUs. A summary of the Company's RSU activity under the Plans was as follows: Number of Restricted Stock Units Weighted-average grant date fair value per share Balance as of December 31, 2021 9,001,949 $ 18.30 Granted 10,514,709 10.70 Vested (994,910) 14.27 Canceled and forfeited (1,854,776) 15.43 Balance as of March 31, 2022 16,666,972 $ 14.07 During the three months ended March 31, 2022, share-based compensation expense recognized for RSUs was $15.3 million. As of March 31, 2022, unrecognized compensation costs related to unvested RSUs was $204.5 million. These costs are expected to be recognized over a period of 3.3 years. Stock Options Under the 2011 Plan and the 2021 Plan, the exercise price of a stock option shall not be less than the fair market value per share of the Company’s common stock on the date of grant (and not less than 110% of the fair market value per share of common stock for grants to stockholders owning more than 10% of the total combined voting power of all classes of stock of the Company, or a 10% Stockholder). Options are exercisable over periods not to exceed ten years from the date of grant (five years for incentive stock options granted to 10% Stockholders). A summary of the Company's stock option activity under both stock incentive plans was as follows: Number of Options Weighted-Average Exercise Price per Share Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value (1) Balance as of December 31, 2021 (2) 44,185,488 $ 13.31 8.46 years $ 279,242 Granted 2,326,800 10.55 Exercised (1,604,022) 1.25 Canceled and forfeited (1,194,748) 5.79 Balance as of March 31, 2022 (2) 43,713,518 $ 13.81 8.32 years $ 140,555 Vested as of March 31, 2022 9,629,103 $ 1.98 6.44 years $ 89,837 (1) Intrinsic value is calculated based on the difference between the exercise price of in-the-money-stock options and the fair value of the common stock as of the respective balance sheet dates. (2) The 2011 Plan allows for early exercise of stock options and these balances include all exercisable stock options regardless of vesting status. As of March 31, 2022, aggregate unrecognized compensation costs related to unvested outstanding stock options, excluding the CEO Long-Term Performance Award, was $88.6 million. These costs are expected to be recognized over a period of 2.6 years. The fair value of stock options granted was estimated using the Black-Scholes option pricing model and the following weighted average assumptions: Three Months Ended March 31, 2022 2021 Dividend yield 0.0% 0.0% Expected volatility 58.62% 49.93% Expected term (in years) 6.08 6.02 Risk-free interest rate 1.99% 0.36% Subsequent to the completion of the IPO, the fair value of the Company’s common stock is determined by the closing price, on the date of grant, of its Class A common stock, which is traded on the Nasdaq Global Select Market. CEO Long-Term Performance Award In April and May 2021, the Company’s board of directors granted the Company’s Chief Executive Officer equity incentive awards in the form of performance-based stock options covering 19,740,923 and 47,267 shares of our Class B common stock with an exercise price of $21.49 and $23.40 per share, respectively, or collectively, the CEO Long-Term Performance Award. The CEO Long-Term Performance Award vests upon the satisfaction of a service condition and the achievement of certain stock price hurdles over a seven year performance period following the expiration of the lock-up period associated with the IPO. The stock price hurdle will be achieved if the average closing price of a share of our Class A common stock during any 90 consecutive trading day period during the performance period equals or exceeds the Company stock price hurdle set forth in the table below. The CEO Long-Term Performance Award is divided into seven equal tranches which vest upon the achievement of the following Company stock price hurdles: Tranche Company Stock Price Hurdle Number of Options Eligible to Vest 1 $67.50 2,826,884 2 $78.98 2,826,884 3 $92.40 2,826,884 4 $108.11 2,826,884 5 $126.49 2,826,884 6 $147.99 2,826,884 7 $173.15 2,826,884 Total 19,788,188 The grant date fair value of the CEO Long-Term Performance Award was estimated using a Monte Carlo simulation model that incorporated multiple stock price paths and probabilities that the Company stock price hurdles are met. The weighted-average grant date fair value of the seven tranches of the CEO Long-Term Performance Award was estimated to be $10.53 per option share. As of March 31, 2022, the aggregate unrecognized compensation cost of the CEO Long-Term Performance Award was $157.1 million, which is expected to be recognized over the remaining derived service period of 3.8 years. Secondary Sales of Common Stock Prior to the completion of the IPO, certain economic interest holders acquired outstanding common stock from current or former employees for a purchase price greater than the Company's estimated fair value at the time of the transactions. During the three months ended March 31, 2022, the Company did not record any share-based compensation expense related to secondary sales of common stock. During the three months ended March 31, 2021, the Company recorded share-based compensation expense for the difference between the price paid and the estimated fair value on the date of the transaction of $5.9 million. |
Warrants to Purchase Common Sto
Warrants to Purchase Common Stock | 3 Months Ended |
Mar. 31, 2022 | |
Equity [Abstract] | |
Warrants to Purchase Common Stock | Warrants to Purchase Common Stock In 2021 and 2020, the Company issued warrants to Customers to purchase up to 1,150,000 and 750,000 shares of the Company’s common stock, respectively. These warrants vest based on certain performance conditions that include issuing a specific percentage of new cards on the Company’s Platform over a defined measurement period and reaching certain annual transaction count thresholds over the contract term, respectively. All warrants have an exercise price of $0.01 per share. These warrants are classified as equity instruments and are treated as consideration payable to a Customer. The grant date fair values of these warrants are recorded as a reduction to net revenue over the term of the respective Customer contract based on the expected pattern of processing volume generated by the Customer and the probability of vesting conditions being met. The aggregate fair values of the warrants issued in 2021 and 2020 were $26.4 million and $5.7 million, respectively. As of March 31, 2022 , 392,171 warrants were vested, and the Company recorded $1.6 million as a reduction of revenue during the three months then ended related to these warrants. The Company recorded an immaterial amount as a reduction of revenue during the three months ended March 31, 2021. Upon vesting, the fair value of the vested warrants are recorded into the Company’s additional paid-in capital. Timing differences caused by the pattern of processing volume generated by the Customer over the term of the contract and the vesting schedules of the warrants can cause differences in the amount of grant date fair value that is credited to additional paid in capital upon vesting and the amount recorded as a reduction in net revenue during any particular reporting period. The fair values of the warrants were estimated using the Black-Scholes option pricing model and the following assumptions as of the grant date of each warrant: March 31, 2021 September 30, 2020 Dividend yield 0.0% 0.0% Expected volatility 50.0% 50.0% Contract term (in years) 4.0 5.0 Risk-free interest rate 0.6% 0.3% |
Net Loss Per Share Attributable
Net Loss Per Share Attributable to Common Stockholders | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share Attributable to Common Stockholders | Net Loss Per Share Attributable to Common Stockholders The Company presents basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. Prior to the completion of the IPO, all series of redeemable convertible preferred stock were considered participating securities. Immediately prior to the completion of the IPO, all shares of redeemable convertible preferred stock then outstanding were converted into shares of Class B common stock. The Company has not allocated net loss attributable to common stockholders to redeemable convertible preferred stock in any period presented because the holders of its redeemable convertible preferred stock were not contractually obligated to share in losses. The Company calculates basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to common stockholders gives effect to all potential shares of common stock, including common stock issuable upon conversion of redeemable convertible preferred stock and redeemable convertible preferred stock warrants, stock options, RSUs and common stock warrants to the extent these are dilutive. The Company calculated basic and diluted net loss per share attributable to common stockholders as follows: Three Months Ended March 31, 2022 2021 Numerator Net loss attributable to Class A and Class B common stockholders $ (60,598) $ (12,838) Denominator Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 542,565,992 130,841,306 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.11) $ (0.10) Basic net loss per share is the same as diluted net loss per share because the Company reported a net loss for the three months ended March 31, 2022 and 2021. The rights, including the liquidation and dividend rights, of the holders of Class A common stock and Class B common stock are identical, except with respect to voting. As the liquidation and dividend rights are identical for Class A common stock and Class B common stock, the undistributed earnings are allocated on a proportionate basis and the resulting loss per share will, therefore, be the same for both Class A common stock and Class B common stock on an individual or combined basis. The Company considered its proportionate share of the potentially dilutive shares issued by its equity method investee in its dilutive net loss per share calculation. All potentially dilutive shares of its equity method investee were excluded from the computation as they would have an anti-dilutive effect. Potentially dilutive securities that were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect were as follows: As of March 31, 2022 2021 Redeemable convertible preferred stock, all series — 351,844,340 Warrants to purchase redeemable convertible preferred stock — 203,610 Warrants to purchase Class B common stock 1,900,000 2,569,528 Stock options outstanding, including early exercise of options 43,713,518 24,332,915 Unvested RSUs outstanding 16,666,972 6,503,203 Shares committed under the ESPP 372,775 — Stock options and RSUs available for future grants 79,545,451 2,493,159 Total 142,198,716 387,946,755 |
Income Tax
Income Tax | 3 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Tax | Income TaxThe income tax expense (benefit) and the associated effective tax rates were not significant for all periods presented. The effective tax rate was lower than the U.S. federal statutory rate primarily because of the domestic valuation allowances. |
Concentration of Risks and Sign
Concentration of Risks and Significant Customers | 3 Months Ended |
Mar. 31, 2022 | |
Risks and Uncertainties [Abstract] | |
Concentration of Risks and Significant Customers | Concentration Risks and Significant Customers Financial instruments that potentially expose the Company to concentration of credit risk consist of cash and cash equivalents, marketable securities, accounts receivable and unbilled Customers' receivable, or collectively, Customers' receivables, and settlements receivable. Cash on deposit with financial institutions may, at times, exceed federally insured limits. Management believes that these financial institutions are financially sound and, accordingly, minimal credit risk exists. Cash and cash equivalents as of March 31, 2022 and December 31, 2021 include $1.2 billion and $1.2 billion, respectively, of investments in three money market mutual funds, which invest primarily in securities issued by the U.S. Government or U.S. Government agencies. As of March 31, 2022, marketable securities were $447.0 million, and there was no concentration of securities of the same issuer with an aggregate fair value greater than 5% of the total balance, except for U.S. Treasuries, which amounted to $412.5 million, or 92% of the marketable securities. All debt securities within the Company's portfolio are investment grade. As of December 31, 2021, marketable securities were $452.9 million, and there was no concentration of securities of the same issuer with an aggregate fair value greater than 5% of the total balance, except for U.S. Treasuries, which amounted to $418.3 million, or 92% of the marketable securities. All debt securities within the Company's portfolio are investment grade. A significant portion of the Company's payment transactions are settled through one Issuing Bank, Sutton Bank. For the three months ended March 31, 2022 and 2021, 86% and 94% of Total Processing Volume, which is the total dollar amount of payments processed through the Company’s Platform, net of returns and chargebacks, was settled through Sutton Bank, respectively. A significant portion of the Company's revenue is derived from one Customer. For the three months ended March 31, 2022 and 2021, this Customer accounted for 66% and 73% of the Company’s net revenue, respectively. As of March 31, 2022, two customers accounted for 10% and 11% of the Company’s accounts receivable, respectively. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions The Company may enter into transactions with related parties. Prior to the completion of the IPO, DFS Services LLC, a holder of more than 5% of the Company's outstanding capital stock pre-IPO, was a related party. During the three months ended March 31, 2021, the Company incurred $11.0 million in Card Network fees, net, recorded within costs of revenue, to PULSE Network LLC, an entity affiliated with DFS Services LLC. The Company has an equity method investment in a private company, which is a related party. During the three months ended March 31, 2022, the Company earned net revenue of $1.8 million from the private company and had $5.1 million in revenue share payable to this private company as of March 31, 2022. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or the SEC, for interim reporting. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on March 11, 2022. The accompanying condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in the Annual Report on Form 10-K. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments of a normal, recurring nature considered necessary for a fair presentation of the Company's consolidated financial position, results of operations, comprehensive loss, and cash flows for the interim periods presented. The interim results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022, or for any other future annual or interim period. |
Use of Estimates | Use of Estimates The preparation of the financial statements requires management to make estimates and assumptions relating to reported amounts of assets and liabilities, disclosure of contingent liabilities, and reported amounts of revenue and expenses. Significant estimates and assumptions relate to the fair value of equity awards and warrants, share-based compensation, the estimation of variable consideration in contracts with Customers, the reserve for contract contingencies and processing errors, the fair value of equity method investments and a purchase call option to acquire the remaining interest in the equity method investee, the incremental borrowing rate used to determine operating lease liabilities, the useful lives of property and equipment, and the collectability of accounts receivable. Actual results could differ materially from these estimates. |
Segment Information | Segment Information The Company operates as a single operating segment. The Company's chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, allocating resources, and evaluating the Company's financial performance. |
Restricted Cash | Restricted Cash Restricted cash consists of deposits with financial institutions that issue payment cards (credit, debit, or prepaid) either on their own behalf or on behalf of businesses that issue customized card products to their end users, or Issuing Banks, to provide the Issuing Bank collateral in the event that Customers’ funds are not deposited at the Issuing Banks in time to settle Customers’ transactions with the networks that provide the infrastructure for settlement and card payment information flows, or Card Networks. Restricted cash also includes cash used to secure a letter of credit for the Company’s lease of its office headquarters in Oakland, California. |
New Accounting Standards Adopted and Not Yet Adopted | New Accounting Standards Not Yet Adopted As an emerging growth company, the Jumpstart Our Business Startups Act, or the JOBS Act, allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption date discussed below reflects this election. In June 2016, the FASB issued ASU No. 2016-13, Financial instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . ASU 2016-13 replaces the incurred loss model with the current expected credit loss, or CECL, model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The CECL model requires a company to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance will be effective for the Company beginning January 1, 2023. The amendment requires a modified retrospective approach by recording a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Early adoption is permitted. The Company is still evaluating the impact this ASU will have on its condensed consolidated financial statements. |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | Disaggregation of Revenue The following table provides information about disaggregated revenue from Customers: Three Months Ended March 31, 2022 2021 Platform services revenue, net $ 160,999 $ 106,453 Other services revenue 5,103 1,530 Total net revenue $ 166,102 $ 107,983 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable | Contract Balances The following table provides information about contract assets and deferred revenue: Contract balance Balance sheet line reference March 31, December 31, Contract assets - current Prepaid expenses and other current assets $ 627 $ 950 Contract assets - non-current Other assets 827 927 Total contract assets $ 1,454 $ 1,877 Deferred revenue - current Accrued expenses and other current liabilities $ 18,839 $ 19,060 Deferred revenue - non-current Other liabilities 3,894 6,107 Total deferred revenue $ 22,733 $ 25,167 |
Marketable Securities (Tables)
Marketable Securities (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Investments [Abstract] | |
Marketable Securities | The amortized cost, unrealized gain (loss), and estimated fair value of the Company's investments in securities available for sale consisted of the following: March 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Marketable securities U.S. government securities $ 420,277 $ — $ (7,824) $ 412,453 Commercial paper 15,972 — — 15,972 Asset-backed securities — — — — Corporate debt securities 18,793 — (172) 18,621 Total marketable securities $ 455,042 $ — $ (7,996) $ 447,046 December 31, 2021 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Marketable securities U.S. government securities $ 420,392 $ — $ (2,107) $ 418,285 Commercial paper 13,878 — — 13,878 Asset-backed securities 2,003 — (1) 2,002 Corporate debt securities 18,731 3 (24) 18,710 Total marketable securities $ 455,004 $ 3 $ (2,132) $ 452,875 |
Schedule of Available-for-sale Securities Reconciliation | The following table summarizes the stated maturities of the Company’s marketable securities: March 31, 2022 December 31, 2021 Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value Due within one year $ 167,575 $ 165,767 $ 64,914 $ 64,879 Due after one year through two years 287,467 281,279 390,090 387,996 Total $ 455,042 $ 447,046 $ 455,004 $ 452,875 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities at Fair Value | The following tables present the fair value hierarchy for assets and liabilities measured at fair value: March 31, 2022 Level 1 Level 2 Level 3 Total Fair Value Cash equivalents Money market funds $ 1,155,612 $ — $ — $ 1,155,612 Marketable securities U.S. government securities 412,453 — — 412,453 Commercial paper — 15,972 — 15,972 Asset-backed securities — — — — Corporate debt securities — 18,621 — 18,621 Total assets $ 1,568,065 $ 34,593 $ — $ 1,602,658 December 31, 2021 Level 1 Level 2 Level 3 Total Fair Value Cash equivalents Money market funds $ 1,213,543 $ — $ — $ 1,213,543 Marketable securities U.S. government securities 418,284 — — 418,284 Commercial paper — 13,878 — 13,878 Asset-backed securities — 2,002 — 2,002 Corporate debt securities — 18,711 — 18,711 Total assets $ 1,631,827 $ 34,591 $ — $ 1,666,418 |
Certain Balance Sheet Compone_2
Certain Balance Sheet Components (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Prepaid Expenses and Other Current Assets | Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: March 31, December 31, Prepaid hosting and data costs $ 22,599 $ 2,455 Prepaid expenses 7,408 6,492 Inventory 4,942 3,940 Prepaid insurance 1,955 3,546 Card program deposits 2,128 2,167 Contract assets 627 950 Other financial instruments — 11,616 Other current assets 4,130 4,451 Prepaid expenses and other current assets $ 43,789 $ 35,617 |
Property and Equipment, net | Property and Equipment, net Property and equipment consisted of the following: March 31, December 31, Leasehold improvements $ 8,110 $ 8,110 Computer equipment 8,921 8,581 Furniture and fixtures 2,459 2,459 Internally developed and purchased software 2,993 2,954 22,483 22,104 Accumulated depreciation and amortization (13,363) (12,417) Property and equipment, net $ 9,120 $ 9,687 |
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: March 31, December 31, Accrued costs of revenue $ 46,726 $ 41,339 Accrued compensation and benefits 17,718 32,954 Deferred revenue 18,839 19,060 Reserve for contract contingencies and processing errors 3,764 3,386 Operating lease liabilities, current portion 3,109 3,021 Accrued professional services 3,785 2,454 Other accrued liabilities 8,205 11,882 Accrued expenses and other current liabilities $ 102,146 $ 114,096 |
Other Liabilities | Other Liabilities Other liabilities consisted of the following: March 31, December 31, Deferred revenue, net of current portion $ 3,894 $ 6,107 Other long-term liabilities 450 450 Other liabilities $ 4,344 $ 6,557 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Components lease costs | The Company's operating lease costs are as follows: Three Months Ended March 31, 2022 2021 Operating lease cost $ 843 $ 869 Variable lease cost 157 112 Short-term lease cost 113 72 Total lease cost $ 1,113 $ 1,053 The weighted average remaining operating lease term and the weighted average discount rate used in the calculation of the Company's lease assets and lease liabilities were as follows: March 31, December 31, Weighted average remaining operating lease term (in years) 3.8 4.1 Weighted average discount rate 7.7% 7.7% Supplemental cash flow information related to the Company's operating leases was as follows: Three Months Ended March 31, 2022 2021 Cash paid for operating lease liabilities $ 1,016 $ 1,033 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ — $ — |
Future minimum lease payments | Maturities of operating lease liabilities by year are as follows as of March 31, 2022: Remainder of 2022 $ 3,096 2023 4,239 2024 4,472 2025 4,599 2026 780 Total lease payments 17,186 Less imputed interest (2,459) Total operating lease liabilities $ 14,727 |
Stock Incentive Plans (Tables)
Stock Incentive Plans (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Schedule of Share-based Compensation Expense Recognized in the Period | The following table presents the share-based compensation expense recognized in the periods presented: Three Months Ended March 31, 2022 2021 Restricted stock units $ 15,345 $ — Stock options 7,659 5,505 CEO Long-Term Performance Award 13,121 — Employee Stock Purchase Plan 880 — Secondary sales of common stock — 5,887 Total $ 37,005 $ 11,392 |
Summary of RSU Activity Under the Plans | A summary of the Company's RSU activity under the Plans was as follows: Number of Restricted Stock Units Weighted-average grant date fair value per share Balance as of December 31, 2021 9,001,949 $ 18.30 Granted 10,514,709 10.70 Vested (994,910) 14.27 Canceled and forfeited (1,854,776) 15.43 Balance as of March 31, 2022 16,666,972 $ 14.07 A summary of the Company's stock option activity under both stock incentive plans was as follows: Number of Options Weighted-Average Exercise Price per Share Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value (1) Balance as of December 31, 2021 (2) 44,185,488 $ 13.31 8.46 years $ 279,242 Granted 2,326,800 10.55 Exercised (1,604,022) 1.25 Canceled and forfeited (1,194,748) 5.79 Balance as of March 31, 2022 (2) 43,713,518 $ 13.81 8.32 years $ 140,555 Vested as of March 31, 2022 9,629,103 $ 1.98 6.44 years $ 89,837 (1) Intrinsic value is calculated based on the difference between the exercise price of in-the-money-stock options and the fair value of the common stock as of the respective balance sheet dates. (2) The 2011 Plan allows for early exercise of stock options and these balances include all exercisable stock options regardless of vesting status. The CEO Long-Term Performance Award is divided into seven equal tranches which vest upon the achievement of the following Company stock price hurdles: Tranche Company Stock Price Hurdle Number of Options Eligible to Vest 1 $67.50 2,826,884 2 $78.98 2,826,884 3 $92.40 2,826,884 4 $108.11 2,826,884 5 $126.49 2,826,884 6 $147.99 2,826,884 7 $173.15 2,826,884 Total 19,788,188 |
Stock Options | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | The fair value of stock options granted was estimated using the Black-Scholes option pricing model and the following weighted average assumptions: Three Months Ended March 31, 2022 2021 Dividend yield 0.0% 0.0% Expected volatility 58.62% 49.93% Expected term (in years) 6.08 6.02 Risk-free interest rate 1.99% 0.36% |
Warrants to Purchase Common S_2
Warrants to Purchase Common Stock (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Equity [Abstract] | |
Schedule of Stockholders' Equity Note, Warrants or Rights | The fair values of the warrants were estimated using the Black-Scholes option pricing model and the following assumptions as of the grant date of each warrant: March 31, 2021 September 30, 2020 Dividend yield 0.0% 0.0% Expected volatility 50.0% 50.0% Contract term (in years) 4.0 5.0 Risk-free interest rate 0.6% 0.3% |
Net Loss Per Share Attributab_2
Net Loss Per Share Attributable to Common Stockholders (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The Company calculated basic and diluted net loss per share attributable to common stockholders as follows: Three Months Ended March 31, 2022 2021 Numerator Net loss attributable to Class A and Class B common stockholders $ (60,598) $ (12,838) Denominator Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 542,565,992 130,841,306 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.11) $ (0.10) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Potentially dilutive securities that were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect were as follows: As of March 31, 2022 2021 Redeemable convertible preferred stock, all series — 351,844,340 Warrants to purchase redeemable convertible preferred stock — 203,610 Warrants to purchase Class B common stock 1,900,000 2,569,528 Stock options outstanding, including early exercise of options 43,713,518 24,332,915 Unvested RSUs outstanding 16,666,972 6,503,203 Shares committed under the ESPP 372,775 — Stock options and RSUs available for future grants 79,545,451 2,493,159 Total 142,198,716 387,946,755 |
Business Overview and Basis o_2
Business Overview and Basis of Presentation (Details) $ / shares in Units, $ in Thousands | May 31, 2021voteshares | Jun. 30, 2021USD ($)$ / sharesshares | Mar. 31, 2022USD ($)shares | Mar. 31, 2021USD ($) | Dec. 31, 2021USD ($)shares |
Initial Public Offering | |||||
Payments of stock issuance costs | $ | $ 0 | $ 1,144 | |||
Preferred Stock, shares authorized (in shares) | shares | 100,000,000 | 100,000,000 | |||
Business Risks and Uncertainties | |||||
Net loss | $ | $ (60,598) | (12,838) | |||
Accumulated deficit | $ | (478,051) | $ (417,453) | |||
Cash and cash equivalents | $ | 1,197,257 | $ 247,630 | $ 1,247,581 | ||
Marketable securities | $ | $ 447,000 | ||||
Class A Common Stock | |||||
Initial Public Offering | |||||
Common stock, shares authorized (in shares) | shares | 1,500,000,000 | 1,500,000,000 | 1,500,000,000 | ||
Number of vote (votes per share) | vote | 1 | ||||
Class B Common Stock | |||||
Initial Public Offering | |||||
Common stock, shares authorized (in shares) | shares | 600,000,000 | 600,000,000 | 600,000,000 | ||
Number of vote (votes per share) | vote | 10 | ||||
Convertible preferred stock, shares, number of shares issued upon conversion (in shares) | shares | 203,610 | 351,844,340 | |||
Preferred stock, convertible, conversion raio | 1 | ||||
Number of common stock warrants converted to Class B common stock warrants (in shares) | shares | 2,569,528 | ||||
Preferred Stock | |||||
Initial Public Offering | |||||
Preferred Stock, shares authorized (in shares) | shares | 100,000,000 | ||||
IPO | Class A Common Stock | |||||
Initial Public Offering | |||||
Sale of stock, number of shares issued in transaction (in shares) | shares | 52,272,727 | ||||
Share price (in dollars per share) | $ / shares | $ 27 | ||||
Proceeds from initial public offering, net of underwriters’ discounts and commissions | $ | $ 1,300,000 | ||||
Payments for commissions and discounts | $ | 91,600 | ||||
Payments of stock issuance costs | $ | $ 7,500 | ||||
Over-Allotment Option | Class A Common Stock | |||||
Initial Public Offering | |||||
Sale of stock, number of shares issued in transaction (in shares) | shares | 6,818,181 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||
Net revenue | $ 166,102 | $ 107,983 |
Platform services revenue, net | ||
Disaggregation of Revenue [Line Items] | ||
Net revenue | 160,999 | 106,453 |
Other services revenue | ||
Disaggregation of Revenue [Line Items] | ||
Net revenue | $ 5,103 | $ 1,530 |
Revenue - Contract Assets and D
Revenue - Contract Assets and Deferred Revenue (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Disaggregation of Revenue [Line Items] | ||
Contract assets - current | $ 627 | $ 950 |
Total contract assets | 1,454 | 1,877 |
Deferred revenue | 18,839 | 19,060 |
Deferred revenue - non-current | 3,894 | 6,107 |
Total deferred revenue | 22,733 | 25,167 |
Prepaid expenses and other current assets | ||
Disaggregation of Revenue [Line Items] | ||
Contract assets - current | 627 | 950 |
Other assets | ||
Disaggregation of Revenue [Line Items] | ||
Contract assets - non-current | 827 | 927 |
Accrued expenses and other current liabilities | ||
Disaggregation of Revenue [Line Items] | ||
Deferred revenue | 18,839 | 19,060 |
Other liabilities | ||
Disaggregation of Revenue [Line Items] | ||
Deferred revenue - non-current | $ 3,894 | $ 6,107 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |||
Deferred revenue recognized during the period | $ 4.5 | $ 0.8 | |
Remaining performance obligation, optional exemption, amount | $ 4.4 | $ 4.2 |
Marketable Securities - Unreali
Marketable Securities - Unrealized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 455,042 | $ 455,004 |
Unrealized Gain | 0 | 3 |
Unrealized Loss | (7,996) | (2,132) |
Marketable securities | 447,046 | 452,875 |
U.S. government securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 420,277 | 420,392 |
Unrealized Gain | 0 | 0 |
Unrealized Loss | (7,824) | (2,107) |
Marketable securities | 412,453 | 418,285 |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 15,972 | 13,878 |
Unrealized Gain | 0 | 0 |
Unrealized Loss | 0 | 0 |
Marketable securities | 15,972 | 13,878 |
Asset-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 0 | 2,003 |
Unrealized Gain | 0 | 0 |
Unrealized Loss | 0 | (1) |
Marketable securities | 0 | 2,002 |
Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 18,793 | 18,731 |
Unrealized Gain | 0 | 3 |
Unrealized Loss | (172) | (24) |
Marketable securities | $ 18,621 | $ 18,710 |
Marketable Securities - Narrati
Marketable Securities - Narrative (Details) - investment | Mar. 31, 2022 | Dec. 31, 2021 |
Investments [Abstract] | ||
Number of marketable securities in unrealized loss positions | 19 | 8 |
Marketable Securities - Stated
Marketable Securities - Stated Maturities of Marketable Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Amortized Cost | ||
Due within one year | $ 167,575 | $ 64,914 |
Due after one year through two years | 287,467 | 390,090 |
Amortized Cost | 455,042 | 455,004 |
Estimated Fair Value | ||
Due within one year | 165,767 | 64,879 |
Due after one year through two years | 281,279 | 387,996 |
Total | $ 447,046 | $ 452,875 |
Fair Value Measurements - Recur
Fair Value Measurements - Recurring Fair Value Measurements (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Assets | ||
Marketable securities | $ 447,046 | $ 452,875 |
Fair Value, Measurements, Recurring | ||
Assets | ||
Total assets | 1,602,658 | 1,666,418 |
Fair Value, Measurements, Recurring | Money market funds | ||
Assets | ||
Money market funds | 1,155,612 | 1,213,543 |
Fair Value, Measurements, Recurring | U.S. government securities | ||
Assets | ||
Marketable securities | 412,453 | 418,284 |
Fair Value, Measurements, Recurring | Commercial paper | ||
Assets | ||
Marketable securities | 15,972 | 13,878 |
Fair Value, Measurements, Recurring | Asset-backed securities | ||
Assets | ||
Marketable securities | 0 | 2,002 |
Fair Value, Measurements, Recurring | Corporate debt securities | ||
Assets | ||
Marketable securities | 18,621 | 18,711 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets | ||
Total assets | 1,568,065 | 1,631,827 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Money market funds | ||
Assets | ||
Money market funds | 1,155,612 | 1,213,543 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | U.S. government securities | ||
Assets | ||
Marketable securities | 412,453 | 418,284 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Commercial paper | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Asset-backed securities | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Corporate debt securities | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets | ||
Total assets | 34,593 | 34,591 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Money market funds | ||
Assets | ||
Money market funds | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | U.S. government securities | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Commercial paper | ||
Assets | ||
Marketable securities | 15,972 | 13,878 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Asset-backed securities | ||
Assets | ||
Marketable securities | 0 | 2,002 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Corporate debt securities | ||
Assets | ||
Marketable securities | 18,621 | 18,711 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets | ||
Total assets | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Money market funds | ||
Assets | ||
Money market funds | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | U.S. government securities | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Commercial paper | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Asset-backed securities | ||
Assets | ||
Marketable securities | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Corporate debt securities | ||
Assets | ||
Marketable securities | $ 0 | $ 0 |
Certain Balance Sheet Compone_3
Certain Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Prepaid hosting and data costs | $ 22,599 | $ 2,455 |
Prepaid expenses | 7,408 | 6,492 |
Inventory | 4,942 | 3,940 |
Prepaid insurance | 1,955 | 3,546 |
Card program deposits | 2,128 | 2,167 |
Contract assets | 627 | 950 |
Other financial instruments | 0 | 11,616 |
Other current assets | 4,130 | 4,451 |
Prepaid expenses and other current assets | 43,789 | $ 35,617 |
Impairment of equity method investments options to purchase remaining interests | $ 11,600 |
Certain Balance Sheet Compone_4
Certain Balance Sheet Components - Property and Equipment, net (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 22,483 | $ 22,104 | |
Accumulated depreciation and amortization | (13,363) | (12,417) | |
Property and equipment, net | 9,120 | 9,687 | |
Depreciation and amortization | 979 | $ 907 | |
Capitalized internal-use software costs | 0 | $ 0 | |
Leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | 8,110 | 8,110 | |
Computer equipment | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | 8,921 | 8,581 | |
Furniture and fixtures | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | 2,459 | 2,459 | |
Internally developed and purchased software | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 2,993 | $ 2,954 |
Certain Balance Sheet Compone_5
Certain Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accrued costs of revenue | $ 46,726 | $ 41,339 |
Accrued compensation and benefits | 17,718 | 32,954 |
Deferred revenue | 18,839 | 19,060 |
Reserve for contract contingencies and processing errors | 3,764 | 3,386 |
Operating lease liabilities, current portion | 3,109 | 3,021 |
Accrued professional services | 3,785 | 2,454 |
Other accrued liabilities | 8,205 | 11,882 |
Accrued expenses and other current liabilities | $ 102,146 | $ 114,096 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued expenses and other current liabilities |
Certain Balance Sheet Compone_6
Certain Balance Sheet Components - Other Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Deferred revenue, net of current portion | $ 3,894 | $ 6,107 |
Other long-term liabilities | 450 | 450 |
Other Liabilities, Noncurrent, Total | $ 4,344 | $ 6,557 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) ft² in Thousands, $ in Millions | 3 Months Ended | ||
Mar. 31, 2022USD ($)ft² | Mar. 31, 2021USD ($) | Dec. 31, 2016ft² | |
Guarantor Obligations | |||
Area of real estate property | ft² | 63 | 19 | |
Purchase commitment | $ 227.6 | ||
Purchase commitment period | 5 years | ||
Company matching contribution, percent | 50.00% | ||
Employer matching contribution, percent of employees' gross pay | 6.00% | ||
Requisite service period (in years) | 1 year | ||
Employer contribution amount | $ 2.2 | $ 0.8 | |
Cloud Computing Service Agreement | |||
Guarantor Obligations | |||
Purchase commitment | 219 | ||
Letter of Credit | |||
Guarantor Obligations | |||
Letters of credit, amount | 1.5 | ||
Restricted Cash | Letter of Credit | |||
Guarantor Obligations | |||
Deposit assets | $ 1.5 |
Commitments and Contingencies_2
Commitments and Contingencies - Lease Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Operating lease cost | $ 843 | $ 869 |
Variable lease cost | 157 | 112 |
Short-term lease cost | 113 | 72 |
Total lease cost | $ 1,113 | $ 1,053 |
Commitments and Contingencies_3
Commitments and Contingencies - Weighted Average Lease Term and Weighted Average Discount Rate (Details) | Mar. 31, 2022 | Dec. 31, 2021 |
Commitments and Contingencies Disclosure [Abstract] | ||
Weighted average remaining operating lease term (in years) | 3 years 9 months 18 days | 4 years 1 month 6 days |
Weighted average discount rate | 7.70% | 7.70% |
Commitments and Contingencies_4
Commitments and Contingencies - Lease Maturity Schedule (Details) $ in Thousands | Mar. 31, 2022USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Remainder of 2022 | $ 3,096 |
2023 | 4,239 |
2024 | 4,472 |
2025 | 4,599 |
2026 | 780 |
Total lease payments | 17,186 |
Less imputed interest | (2,459) |
Total operating lease liabilities | $ 14,727 |
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Accounts Payable and Accrued Liabilities |
Commitments and Contingencies_5
Commitments and Contingencies - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Cash paid for operating lease liabilities | $ 1,016,000 | $ 1,033 |
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities | $ 0 | $ 0 |
Stock Incentive Plans - Schedul
Stock Incentive Plans - Schedule of Share-based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Share-based compensation expense | $ 37,005 | $ 11,392 |
Restricted stock units | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Share-based compensation expense | 15,345 | 0 |
Stock options | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Share-based compensation expense | 7,659 | 5,505 |
CEO Long-Term Performance Award | Chief Executive Officer | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Share-based compensation expense | 13,121 | 0 |
Employee Stock Purchase Plan | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Share-based compensation expense | 880 | 0 |
Secondary sales of common stock | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Share-based compensation expense | $ 0 | $ 5,887 |
Stock Incentive Plans - Narrati
Stock Incentive Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | |||
May 31, 2021 | May 30, 2021 | Apr. 30, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Share-based compensation expense | $ 37,005 | $ 11,392 | |||
Stock Options | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Granted (in shares) | 2,326,800 | ||||
Granted (in dollars per share) | $ 10.55 | ||||
Stock Options | 2021 Stock Option and Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Fair market value of one share of common stock threshold | 110.00% | ||||
Secondary sales of common stock | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Share-based compensation expense | $ 0 | 5,887 | |||
CEO Long-Term Performance Award | Chief Executive Officer | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Share-based compensation expense | $ 13,121 | 0 | |||
Award vesting period (in years) | 7 years | ||||
Compensation costs related to unvested outstanding stock options, period for recognition (in years) | 3 years 9 months 18 days | ||||
Granted (in shares) | 47,267 | 19,740,923 | |||
Granted (in dollars per share) | $ 23.40 | $ 21.49 | |||
Weighted average grant date fair value (in dollars per share) | $ 10.53 | ||||
Expected cost to be recognized over remaining derived service period | $ 157,100 | ||||
Restricted Stock Units (RSUs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Share-based compensation expense | 15,345 | 0 | |||
CEO Long-term performance awards | $ 204,500 | ||||
Compensation costs related to unvested outstanding stock options, period for recognition (in years) | 3 years 3 months 18 days | ||||
Stock options | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Share-based compensation expense | $ 7,659 | $ 5,505 | |||
Compensation costs related to unvested outstanding stock options, period for recognition (in years) | 2 years 7 months 6 days | ||||
Compensation costs related to unvested outstanding stock options | $ 88,600 | ||||
Restricted Stock Units with Service Condition | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 4 years | ||||
Class A Common Stock | Stock Options | 2021 Stock Option and Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Fair market value of one share of common stock threshold | 110.00% | ||||
Combined voting power of stockholder, 10% Stockholder | 10.00% | ||||
Expiration period (in years) | 10 years | ||||
Class A Common Stock | Stock options, 10% Stockholders | 2021 Stock Option and Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Combined voting power of stockholder, 10% Stockholder | 10.00% | ||||
Expiration period (in years) | 5 years | ||||
Class A Common Stock | Stock options | 2021 Stock Option and Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Purchase price of common stock, percent | 85.00% |
Stock Incentive Plans - Restric
Stock Incentive Plans - Restricted Stock Units (Details) - Restricted Stock Units (RSUs) | 3 Months Ended |
Mar. 31, 2022$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Balance at beginning of the period (in shares) | shares | 9,001,949 |
Granted (in shares) | shares | 10,514,709 |
Vested (in shares) | shares | (994,910) |
Canceled and forfeited (in shares) | shares | (1,854,776) |
Balance at the end of the period (in shares) | shares | 16,666,972 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | |
Balance at the beginning of the period (in dollars per share) | $ / shares | $ 18.30 |
Grant (in dollars per share) | $ / shares | 10.70 |
Vested (in dollars per share) | $ / shares | 14.27 |
Canceled and forfeited (in dollars per share) | $ / shares | 15.43 |
Balance at the end of the period (in dollars per share) | $ / shares | $ 14.07 |
Stock Incentive Plans - Summary
Stock Incentive Plans - Summary of Stock Option Activity Under Stock Incentive Plan (Details) - Stock Options - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Number of Options | ||
Balance at the beginning of the period (in shares) | 44,185,488 | |
Granted (in shares) | 2,326,800 | |
Exercised (in shares) | (1,604,022) | |
Canceled and forfeited (in shares) | (1,194,748) | |
Balance at the end of the period (in shares) | 43,713,518 | 44,185,488 |
Weighted-Average Exercise Price per Share | ||
Balance at the beginning of the period (in dollars per share) | $ 13.31 | |
Granted (in dollars per share) | 10.55 | |
Exercised (in dollars per share) | 1.25 | |
Canceled and forfeited (in dollars per share) | 5.79 | |
Balance at the end of the period (in dollars per share) | $ 13.81 | $ 13.31 |
Option Activity, Additional Disclosures | ||
Options outstanding, Weighted Average Remaining Contractual Life (Years) | 8 years 3 months 25 days | 8 years 5 months 15 days |
Options outstanding, Aggregate Intrinsic Value (in USD) | $ 140,555 | $ 279,242 |
Options Vested as of September 30, 2021, Number of Options (in shares) | 9,629,103 | |
Options Vested as of September 30, 2021, Exercise Price per Share (in dollars per share) | $ 1.98 | |
Options Vested, Weighted Average Remaining Contractual Life (Years) | 6 years 5 months 8 days | |
Options Vested, as of September 30, 2021, Aggregate Intrinsic Value (in USD) | $ 89,837 |
Stock Incentive Plans - Weighte
Stock Incentive Plans - Weighted Average Assumptions (Details) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | ||
Dividend yield | 0.00% | 0.00% |
Expected volatility | 58.62% | 49.93% |
Expected term (in years) | 6 years 29 days | 6 years 7 days |
Risk-free interest rate | 1.99% | 0.36% |
Stock Incentive Plans - CEO Per
Stock Incentive Plans - CEO Performance Awards (Details) - CEO Long-Term Performance Award - Chief Executive Officer | 3 Months Ended |
Mar. 31, 2022$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Number of Options Eligible to Vest (in shares) | 19,788,188 |
Tranche 1 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 67.50 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Tranche 2 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 78.98 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Tranche 3 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 92.40 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Tranche 4 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 108.11 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Tranche 5 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 126.49 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Tranche 6 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 147.99 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Tranche 7 | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Company Stock Price Hurdle (in dollars per share) | $ / shares | $ 173.15 |
Number of Options Eligible to Vest (in shares) | 2,826,884 |
Warrants to Purchase Common S_3
Warrants to Purchase Common Stock - Narrative (Details) - Common Stock Warrants - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | ||
Mar. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Class of Warrant or Right [Line Items] | |||
Number of securities called by each warrant (in shares) | 1,150,000 | 750,000 | |
Exercise price of warrants (in dollars per share) | $ 0.01 | ||
Redeemable convertible preferred stock warrant liabilities | $ 26.4 | $ 5.7 | |
Vested warrants outstanding (in shares) | 392,171 | ||
Class of warrant or right, reduction to net revenues in the period | $ (1.6) |
Warrants to Purchase Common S_4
Warrants to Purchase Common Stock - Measurement Inputs (Details) | Sep. 30, 2021 | Mar. 31, 2021 |
March 2021 Common Stock Warrants | ||
Class of Warrant or Right [Line Items] | ||
Warrant term (in years) | 4 years | |
March 2021 Common Stock Warrants | Dividend yield | ||
Class of Warrant or Right [Line Items] | ||
Measurement input (percent) | 0 | |
March 2021 Common Stock Warrants | Expected volatility | ||
Class of Warrant or Right [Line Items] | ||
Measurement input (percent) | 0.500 | |
March 2021 Common Stock Warrants | Risk-free interest rate | ||
Class of Warrant or Right [Line Items] | ||
Measurement input (percent) | 0.006 | |
September 2020 Common Stock Warrants | ||
Class of Warrant or Right [Line Items] | ||
Warrant term (in years) | 5 years | |
September 2020 Common Stock Warrants | Dividend yield | ||
Class of Warrant or Right [Line Items] | ||
Measurement input (percent) | 0 | |
September 2020 Common Stock Warrants | Expected volatility | ||
Class of Warrant or Right [Line Items] | ||
Measurement input (percent) | 0.500 | |
September 2020 Common Stock Warrants | Risk-free interest rate | ||
Class of Warrant or Right [Line Items] | ||
Measurement input (percent) | 0.003 |
Net Loss Per Share Attributab_3
Net Loss Per Share Attributable to Common Stockholders - EPS (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Earnings Per Share [Abstract] | ||
Net loss attributable to Class A and Class B common stockholders | $ (60,598) | $ (12,838) |
Weighted-average shares used in computing net loss per share attributable to common stockholders - Diluted (in shares) | 542,565,992 | 130,841,306 |
Weighted-average shares used in computing net loss per share attributable to common stockholders - Basic (in shares) | 542,565,992 | 130,841,306 |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.11) | $ (0.10) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.11) | $ (0.10) |
Net Loss Per Share Attributab_4
Net Loss Per Share Attributable to Common Stockholders - Antidilutive Securities (Details) - shares | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 142,198,716 | 387,946,755 |
Redeemable convertible preferred stock, all series | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 0 | 351,844,340 |
Warrants to purchase redeemable convertible preferred stock | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 0 | 203,610 |
Warrants to purchase Class B common stock | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 1,900,000 | 2,569,528 |
Stock options outstanding, including early exercise of options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 43,713,518 | 24,332,915 |
Restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 16,666,972 | 6,503,203 |
Shares committed under the ESPP | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 372,775 | 0 |
Stock options and RSUs available for future grants | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 79,545,451 | 2,493,159 |
Concentration of Risks and Si_2
Concentration of Risks and Significant Customers (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2022USD ($)investment | Mar. 31, 2021USD ($) | Dec. 31, 2021USD ($) | |
Concentration Risk [Line Items] | |||
Cash and cash equivalents | $ 1,197,257 | $ 247,630 | $ 1,247,581 |
Marketable securities | 447,046 | 452,875 | |
Credit Concentration Risk | Investments | |||
Concentration Risk [Line Items] | |||
Cash and cash equivalents | $ 1,200,000 | 1,200,000 | |
Number of investments | investment | 3 | ||
Credit Concentration Risk | Debt Securities, Available-For-Sale | |||
Concentration Risk [Line Items] | |||
Marketable securities | $ 412,500 | $ 418,300 | |
Credit Concentration Risk | Debt Securities, Available-For-Sale | Marketable Securities | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 92.00% | 92.00% | |
Credit Concentration Risk | Accounts Receivable | Sutton Bank | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 86.00% | 94.00% | |
Customer Concentration Risk | Accounts Receivable | Largest customer | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 10.00% | ||
Customer Concentration Risk | Accounts Receivable | Second largest customer | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 11.00% | ||
Customer Concentration Risk | Revenue from Contract with Customer Benchmark | Largest customer | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 66.00% | 73.00% |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | May 31, 2021 | |
DFS Services LLC | DFS Services LLC | DFS Services LLC | |||
Related Party Transaction [Line Items] | |||
Ownership interest by related party | 5.00% | ||
PULSE Network LLC | Card Network Fees, Net | |||
Related Party Transaction [Line Items] | |||
Expenses from transactions with related parties | $ 11 | ||
Connexpay, LLC | |||
Related Party Transaction [Line Items] | |||
Revenue from related parties | $ 1.8 | ||
Revenue share payable | $ 5.1 |